Gong Chuxiong, Su Zhongjian, Li Qinhong, Li Hongyan, Wang Ziyu, Gao Huiing, Li Yamin, Liu Xiaomei, Deng Lili
Department of Cardiovascular Medicine, Kunming Children's Hospital, Kunming, Yunnan, China.
Department of Cardiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Front Cardiovasc Med. 2025 Apr 29;12:1543767. doi: 10.3389/fcvm.2025.1543767. eCollection 2025.
Kawasaki disease is an acute immune vasculitis that often has a poor prognosis when complicated by coronary artery lesions. Our study aims to construct a risk model for Kawasaki disease complicated by coronary artery lesions and validate it in different clinical characteristic subgroups, optimizing personalized and precise management of Kawasaki disease to improve patient outcomes.
First, we compared each factor between the groups with and without coronary artery damage. We then used LASSO analysis to further filter for factors that were more significant in predicting outcomes. The selected factors were used to construct the risk model. The model was evaluated using ROC curves, calibration curves, and DCA, and was internally validated using 5-fold cross-validation. Finally, we also conducted subgroup analyses based on factors such as age stages and sex.
Through univariate analysis, LASSO analysis, and correlation analysis, we identified WBC, PLT, CRP, ALB, Na, Time to IVIG treatment, and symptoms of limb as the key factors for constructing the risk model. The model achieved an area under the curve of 0.815(95%CI: 0.779-0.851). Additionally, calibration curves, DCA, and 10-fold cross-validation demonstrated that the model has good predictive performance. The predictive efficacy of the model was also satisfactory across various subgroups.
Our study has constructed a risk model for Kawasaki disease complicated by coronary artery lesions in the Chinese population that demonstrates good predictive performance, and it has been validated successfully across multiple subgroups.
川崎病是一种急性免疫性血管炎,合并冠状动脉病变时预后往往较差。本研究旨在构建川崎病合并冠状动脉病变的风险模型,并在不同临床特征亚组中进行验证,以优化川崎病的个性化精准管理,改善患者预后。
首先,我们比较了有和没有冠状动脉损伤的两组之间的各项因素。然后使用LASSO分析进一步筛选出对预测结局更有意义的因素。将所选因素用于构建风险模型。使用受试者工作特征曲线(ROC曲线)、校准曲线和决策曲线分析(DCA)对模型进行评估,并使用五折交叉验证进行内部验证。最后,我们还根据年龄阶段和性别等因素进行了亚组分析。
通过单因素分析、LASSO分析和相关性分析,我们确定白细胞(WBC)、血小板(PLT)、C反应蛋白(CRP)、白蛋白(ALB)、钠(Na)、静脉注射免疫球蛋白(IVIG)治疗时间以及肢体症状为构建风险模型的关键因素。该模型的曲线下面积为0.815(95%可信区间:0.779-0.851)。此外,校准曲线、DCA和十折交叉验证表明该模型具有良好的预测性能。该模型在各个亚组中的预测效能也令人满意。
我们的研究构建了中国人群川崎病合并冠状动脉病变的风险模型,该模型具有良好的预测性能,并在多个亚组中成功得到验证。